HAPPE Spine
Medical device company developing hydroxyapatite-reinforced porous PEEK biomaterials and monolithic spinal interbody implants. The organization reports a patent-backed materials and manufacturing platform that produces implants with interconnected cancellous porosity, exposed hydroxyapatite on pore surfaces, and bone-like mechanical properties. Activities described on the site include preclinical testing, regulatory submissions (510(k)), manufacturing scale-up and early clinical deployment.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Implantable medical device with varied composition and porosity, and method for forming same
US-12570028-B2
View DetailsImplantable medical device with varied composition and porosity, and method for forming same
US-12005616-B2
View DetailsImplantable medical device with thermoplastic composite body and method for forming thermoplastic composite body
US-11911535-B2
View DetailsImplantable medical device with thermoplastic composite body and method for forming thermoplastic composite body
US-11607476-B2
View DetailsImplantable medical device with varied composition and porosity, and method for forming same
US-11426904-B2
View Details
Implantable medical device with varied composition and porosity, and method for forming same
US-12570028-B2
View DetailsImplantable medical device with varied composition and porosity, and method for forming same
US-12005616-B2
View DetailsImplantable medical device with thermoplastic composite body and method for forming thermoplastic composite body
US-11911535-B2
View DetailsImplantable medical device with thermoplastic composite body and method for forming thermoplastic composite body
US-11607476-B2
View DetailsImplantable medical device with varied composition and porosity, and method for forming same
US-11426904-B2
View DetailsProducts
Cervical interbody fusion cage manufactured from hydroxyapatite‑reinforced porous PEEK
A monolithic cervical interbody fusion implant combining dense load-bearing regions and through-thickness interconnected porous regions of hydroxyapatite-reinforced PEEK intended to support endplate-to-endplate bone in-growth, hydrophilic bioactive surfaces, and radiolucent imaging with radiopaque markers.
Cervical interbody fusion cage manufactured from hydroxyapatite‑reinforced porous PEEK
A monolithic cervical interbody fusion implant combining dense load-bearing regions and through-thickness interconnected porous regions of hydroxyapatite-reinforced PEEK intended to support endplate-to-endplate bone in-growth, hydrophilic bioactive surfaces, and radiolucent imaging with radiopaque markers.
Expertise Areas
- Orthopaedic biomaterials
- Interbody spinal fusion device development
- Biomaterials engineering and microstructure control
- Preclinical testing and animal models
Key Technologies
- Hydroxyapatite-reinforced porous PEEK
- Dual-density monolithic molding of thermoplastics
- Interconnected cancellous porosity (200–500 µm pores)
- Spherical porogen templating
News & Updates
Announcement of FDA clearance for the cervical interbody fusion system.
Announcement of first clinical case using the cervical interbody fusion system.
Press release reporting reaching 1,000 patients treated with the cervical interbody fusion system.
Announcement of a $3.35 million Series A capital raise to support regulatory testing, manufacturing scale-up and commercialization.
Multiple issued U.S. utility patents covering implantable devices with interconnected porosity and embedded bioactive particles, and processes for forming implants with regions of differing porosity.
Announcement of FDA clearance for the cervical interbody fusion system.
Announcement of first clinical case using the cervical interbody fusion system.
Press release reporting reaching 1,000 patients treated with the cervical interbody fusion system.
Announcement of a $3.35 million Series A capital raise to support regulatory testing, manufacturing scale-up and commercialization.
Multiple issued U.S. utility patents covering implantable devices with interconnected porosity and embedded bioactive particles, and processes for forming implants with regions of differing porosity.